PDL BIOPHARMA, INC. 4 SEC Filings

Filed On	Filing
03 Feb 2021	Form 4: Silver Point Capital L.p., 10% owner and 2 others Bought 187,061 shares ($383K)
04 Jan 2021	Form 4: Silver Point Capital L.p., 10% owner and 2 others Bought 6,325,213 shares ($15.8M)
31 Dec 2020	Form 4: Gryska David W, Director Sold 20,000 shares ($54.8K)
29 Dec 2020	Form 4: Silver Point Capital L.p., 10% owner and 2 others Bought 128,000 shares ($339K) · Bought 235,000 shares ($635K) · Bought 268,600 shares ($723K)
23 Dec 2020	Form 4: Silver Point Capital L.p., 10% owner and 2 others Bought 230,000 shares ($605K) · Bought 850,000 shares ($2.2M) · Bought 485,000 shares ($1.26M)
22 Dec 2020	Form 4: Mclaughlin John Peter, Director Sold 50,000 shares ($131K) · Sold 277,934 shares ($725K)
18 Dec 2020	Form 4: Silver Point Capital L.p., 10% owner and 2 others Bought 1,350,000 shares ($3.48M) · Bought 398,000 shares ($1.04M)
17 Dec 2020	Form 4: Stone Christopher Lewis, VP, Gen. Counsel & Secretary Sold 200,000 shares ($512K)
17 Dec 2020	Form 4: Monnet Dominique, President and CEO Sold 500,000 shares ($1.3M)
17 Dec 2020	Form 4: Gryska David W, Director Sold 75,000 shares ($201K)
15 Dec 2020	Form 4: Silver Point Capital L.p., 10% owner and 2 others Bought 450,000 shares ($1.1M) · Bought 640,000 shares ($1.68M) · Bought 1,000,000 shares ($2.59M)
09 Dec 2020	Form 4: Gryska David W, Director Received 66,050 shares by exercise or conversion ($108K)
04 Dec 2020	Form 4: Stone Christopher Lewis, VP, Gen. Counsel & Secretary Returned 11,544 shares to the issuer
04 Dec 2020	Form 4: Gryska David W, Director Sold 75,000 shares ($189K)
24 Nov 2020	Form 4: O'Farrell Elizabeth G., Director Sold 25,826 shares ($63K)
24 Nov 2020	Form 4: Gryska David W, Director Sold 50,000 shares ($122K)
20 Nov 2020	Form 4: O'Farrell Elizabeth G., Director Sold 63,291 shares ($151K)
20 Nov 2020	Form 4: Gryska David W, Director Received 60,000 shares by exercise or conversion ($98.4K)
20 Nov 2020	Form 4: Bazaar Alan Lee, Director Received 37,080 shares by exercise or conversion ($63.4K) · Gave up 26,642 shares to cover exercise price or tax ($63.4K) · Sold 33,435 shares ($81K)
19 Nov 2020	Form 4: Gryska David W, Director Sold 100,000 shares ($240K) · Sold 50,000 shares ($120K)

Comments